Pages that link to "Q42656099"
Jump to navigation
Jump to search
The following pages link to Anatomy of a founder effect: myotonic dystrophy in Northeastern Quebec (Q42656099):
Displaying 19 items.
- Therapeutics development in myotonic dystrophy type 1. (Q30425796) (← links)
- Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population (Q33685609) (← links)
- Mutations in C5ORF42 cause Joubert syndrome in the French Canadian population (Q34031174) (← links)
- Admixed ancestry and stratification of Quebec regional populations (Q34163262) (← links)
- Congenital myotonic dystrophy in a national registry (Q34187766) (← links)
- Native American admixture in the Quebec founder population (Q34775740) (← links)
- Obesity and type 2 diabetes in Northern Canada's remote First Nations communities: the dietary dilemma (Q37820073) (← links)
- Neurogenetic disorders in the Basque population (Q38273952) (← links)
- Myotonic dystrophy: disease repeat range, penetrance, age of onset, and relationship between repeat size and phenotypes (Q39141248) (← links)
- Myotonic dystrophy type 1. (Q40715212) (← links)
- Genomic and genealogical investigation of the French Canadian founder population structure. (Q45985294) (← links)
- Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink. (Q47635841) (← links)
- Relaxed Selection During a Recent Human Expansion. (Q48215539) (← links)
- Oral motor movements and swallowing in patients with myotonic dystrophy type 1. (Q48983321) (← links)
- Design and rationale of a genetic cohort study on congenital cardiac disease: experiences from a multi-institutional platform in Quebec (Q57239665) (← links)
- Myotonic dystrophy (Q87411199) (← links)
- Molecular Diagnosis of Myotonic Dystrophy (Q88530017) (← links)
- WITHDRAWN: Evidence for a relatively high proportion of DM2 mutations in a large group of Polish patients (Q89029766) (← links)
- Robust Preimplantation Genetic Testing Strategy for Myotonic Dystrophy Type 1 by Bidirectional Triplet-Primed Polymerase Chain Reaction Combined With Multi-microsatellite Haplotyping Following Whole-Genome Amplification (Q91971991) (← links)